Literature DB >> 1639618

Visual acuities and scotomas after one week levodopa administration in human amblyopia.

I Gottlob1, J Charlier, R D Reinecke.   

Abstract

The authors previously showed that a single dose of levodopa improves the contrast sensitivity and decreases the size of fixation point scotomas in amblyopic patients. In the present study, they investigated the effect of levodopa after 1 wk of daily administration using a cross-over, double masked design. The decrease of fixation point scotomas was confirmed with automatic static perimetry. An improvement of visual acuity occurred in 70% of the patients after 1 wk of levodopa administration compared to only 22% in the authors' previous study using one single dose. The improvements in visual acuities and visual fields persisted even after the levodopa administration was completed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639618

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  18 in total

1.  Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up.

Authors:  Vincenzo Parisi
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

2.  Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma.

Authors:  Vincenzo Parisi; Marco Centofanti; Lucia Ziccardi; Lucia Tanga; Manuele Michelessi; Gloria Roberti; Gianluca Manni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-26       Impact factor: 3.117

3.  Efficiency of the occlusion therapy with and without levodopa-carbidopa in amblyopic children-A tertiary care centre experience.

Authors:  Ishfaq Ahmad Sofi; Satish K Gupta; Anuradha Bharti; Tariq G Tantry
Journal:  Int J Health Sci (Qassim)       Date:  2016-04

Review 4.  The treatment of amblyopia: current practice and emerging trends.

Authors:  Eleni Papageorgiou; Ioannis Asproudis; Gail Maconachie; Evangelia E Tsironi; Irene Gottlob
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-31       Impact factor: 3.117

5.  Levodopa as a possible treatment of visual loss in nonarteritic anterior ischemic optic neuropathy.

Authors:  Deanna P Lyttle; Lenworth N Johnson; Edward A Margolin; Richard W Madsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-20       Impact factor: 3.117

6.  Electro-oculographic abnormalities in amblyopia.

Authors:  C Williams; D Papakostopoulos
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

7.  Functional magnetic resonance imaging (fMRI) and effects of L-dopa on visual function in normal and amblyopic subjects.

Authors:  Gary L Rogers
Journal:  Trans Am Ophthalmol Soc       Date:  2003

8.  Visual acuities and scotomas after 3 weeks' levodopa administration in adult amblyopia.

Authors:  I Gottlob; S S Wizov; R D Reinecke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-07       Impact factor: 3.117

9.  Effect of oral CDP-choline on visual function in young amblyopic patients.

Authors:  Michela Fresina; Anna Dickmann; Annabella Salerni; Fabio De Gregorio; Emilio C Campos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-19       Impact factor: 3.117

10.  Effect of citicoline on visual acuity in amblyopia: preliminary results.

Authors:  E C Campos; C Schiavi; P Benedetti; R Bolzani; V Porciatti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-05       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.